ftInvstr
AAREYDRUGS · Healthcare ₹109.0 -0.19% Mkt Cap ₹308 Cr

AAREYDRUGS

Healthcare Drug Manufacturers - Specialty & Generic
₹109.0
-0.19% today · 30d +3.61%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for AAREYDRUGS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹189 Cr
+75.28% YoY
NET PROFIT
₹2 Cr
+231.29% YoY
OPM
2.07%
-0.25pp YoY
EPS
₹0.55
PE 74.05
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
AAREYDRUGS74.05—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
53
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth MUTED 35
Profitability AVERAGE 30
Technicals NEUTRAL 67
Risk LOW 90
Key Stats
TTM PE
74.05
P/B
2.06
52W HIGH
₹114.8
OFF HIGH
-5.05%
DIV YIELD
0.0%
MKT CAP
₹308 Cr
◉ Active Signals
MACDNeutral-0.3311
RSI(14)Neutral54.17
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AAREYDRUGS and at what entry.

Sign up freeSign in